• Passa alla navigazione primaria
  • Passa al contenuto principale
BC

biochimica clinica

it_IT Italian
it_IT Italian en_US English
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

OPINIONI - Opinions

Volume:

Biochimica Clinica 2020; 44(2) 157-167

Pubblicato on-line:

Aprile 15, 2020

DOI:

10.19186/BC_2020.027

Scarica in PDF:
Autenticazione richiesta

Catene leggere libere nella diagnostica liquorale della sclerosi multipla: possibile alternativa alla ricerca delle bande oligoclonali?
Free light chains in diagnosis of multiple sclerosis: an alternative to oligoclonal bands?

AUTORI

Bruna Lo Sasso1, Giulia Bivona1, Caterina Maria Gambino1, Patrizia Altavilla2, Emanuela Maria Pappalardo2,
Giuseppina Candore1, Marcello Ciaccio1,2
1Dipartimento di Biomedicina, Neuroscienze e Diagnostica avanzata, Istituto di Biochimica Clinica, Medicina Molecolare Clinica e Medicina di Laboratorio, Università degli Studi di Palermo
2Dipartimento di Medicina di Laboratorio, Ospedale Universitario P. Giaccone, Palermo

ABSTRACT

Free light chains in diagnosis of multiple sclerosis: an alternative to oligoclonal bands?

Multiple sclerosis (MS) is one of the most common causes of neurological disability in young adults. MS presents heterogeneous clinical manifestations and both genetic and environmental factors are considered involved in the risk of developing the disease. The clinical diagnosis is rather complex reflecting the heterogeneity of the pathology. The diagnostic criteria, frequently modified over the years, require clinical symptoms, presence of typical lesions detected by magnetic resonance imaging and laboratory findings. The laboratory examination of the cerebrospinal fluid (CSF) allows an evaluation of inflammatory processes confined to the central nervous system reflecting the changes in the immunological pattern due to the progression of the pathology, playing thus an important role in the diagnosis and monitoring of MS. The detection of the oligoclonal bands (OCBs) is recognized as a “gold standard” for laboratory diagnosis of MS, although it suffers from methodological limitations. Indeed, OCBs assay is a manual multistep procedure, time-consuming that requires a subjective interpretation. In the last years, the measurement of the free light chains (FLC) in CSF appeared to assist in the diagnosis of MS. This procedure has been presented as a simpler and cheaper tool than the qualitative detection of OCBs. This article examines the current knowledge about the laboratory diagnostic of CSF, investigating both the validated method (OCBs) and the alternative biomarkers of immunoglobulins intrathecal synthesis, as the quantification of FLC in CSF.

BIBLIOGRAFIA